SCHEMBL6992801

SCHEMBL6992801

COc1nn(C(C)CCCc2ccccc2)c(N)c1C#N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.40
IKBKB O14920 1/20 0.36
HTR2A P28223 1/20 0.36
RPS27 P42677 1/20 0.35
GAA P10253 3/20 0.35
GRM2 Q14416 1/20 0.35
KDM4E B2RXH2 2/20 0.35
ALDH1A1 P00352 2/20 0.35
HPGD P15428 2/20 0.35
MAPT P10636 1/20 0.35
ALOX15 P16050 1/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
GLA P06280 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6997684 0.87 TSHR (0.37) TSHRIKBKBRPS27GAAGRM2
SCHEMBL27468086 0.83 GAA (0.52) TSHRIKBKBRPS27GAAGRM2
SCHEMBL6992460 0.79 PDE4A (0.35) HTR2AALDH1A1HPGDKMT2APDE4A
SCHEMBL6998546 0.79 RPS27 (0.41) TSHRRPS27KDM4EALDH1A1HPGD
SCHEMBL6997571 0.74 ALDH1A1 (0.38) TSHRIKBKBGAAKDM4EALDH1A1
SCHEMBL6997387 0.72 TSHR (0.50) TSHRIKBKBGAAGRM2KDM4E
SCHEMBL7460074 0.70 ALDH1A1 (0.35) GAAALDH1A1HPGDKMT2APDE4A
SCHEMBL22863804 0.69 ADORA1 (0.39) TSHRGAAKDM4EALDH1A1HPGD
SCHEMBL3615656 0.68 GAA (0.61) TSHRGAAKDM4EALDH1A1HPGD
SCHEMBL7850685 0.68 NOS3 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0973774-B1 1,5-DIHYDRO-PYRAZOLO 3,4-D]-PYRIMIDINONE DERIVATIVES BAYER AG (DE) 2003-01-22 EP disclosed
US-6174884-B1 CARDIOVASCULAR DISORDERS; CEREBROVASCULAR DISEASES; VASCULAR SYSTEM DISORDERS, ESPECIALLY THE PERIPHERAL BLOOD VESSELS; UROGENITAL DISORDERS; HYPOTENSIVE AGENTS; ANTIARRYTHMIA AND -ISCHEMIC AGENTS; PHOSPHODIESTERASE ACTIVITY BAYER AKTIENGESELLSCHAFT (DE) 2001-01-16 US disclosed
EP-0973774-A1 1,5-DIHYDRO-PYRAZOLO 3,4-D]-PYRIMIDINONE DERIVATIVES BAYER AG (DE) 2000-01-26 EP disclosed
WO-1998040384-A1 1,5-DIHYDRO-PYRAZOLO[3,4-D]-PYRIMIDINONE DERIVATIVES BAYER AKTIENGESELLSCHAFT (DE) 1998-09-17 WO disclosed